TW200736237A - Alkyl sulfonamide derivatives - Google Patents

Alkyl sulfonamide derivatives

Info

Publication number
TW200736237A
TW200736237A TW095118082A TW95118082A TW200736237A TW 200736237 A TW200736237 A TW 200736237A TW 095118082 A TW095118082 A TW 095118082A TW 95118082 A TW95118082 A TW 95118082A TW 200736237 A TW200736237 A TW 200736237A
Authority
TW
Taiwan
Prior art keywords
subject
compound
provides
amount
treating
Prior art date
Application number
TW095118082A
Other languages
English (en)
Chinese (zh)
Inventor
Vrej Jubian
Mathivanan Packiarajan
Hermogenes Jimenez
Emily Reinhard
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of TW200736237A publication Critical patent/TW200736237A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW095118082A 2005-06-23 2006-05-22 Alkyl sulfonamide derivatives TW200736237A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15979405A 2005-06-23 2005-06-23

Publications (1)

Publication Number Publication Date
TW200736237A true TW200736237A (en) 2007-10-01

Family

ID=37595447

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095118082A TW200736237A (en) 2005-06-23 2006-05-22 Alkyl sulfonamide derivatives

Country Status (13)

Country Link
JP (1) JP2008546787A (fr)
KR (1) KR20080018206A (fr)
CN (1) CN101203499A (fr)
AR (1) AR054480A1 (fr)
AU (1) AU2006262319A1 (fr)
BR (1) BRPI0612270A2 (fr)
CA (1) CA2613377A1 (fr)
EA (1) EA200800111A1 (fr)
IL (1) IL187894A0 (fr)
MX (1) MX2007015998A (fr)
NO (1) NO20080411L (fr)
TW (1) TW200736237A (fr)
WO (1) WO2007002126A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2650683A1 (fr) 2006-04-28 2007-11-08 Shionogi & Co., Ltd. Derive amine ayant une activite antagoniste du recepteur y5 du npy
SA08290668B1 (ar) 2007-10-25 2012-02-12 شيونوجي آند كو.، ليمتد مشتقات أمين لها نشاط مضاد لمستقبل npy y5 واستخداماتها
US8227618B2 (en) 2009-04-23 2012-07-24 Shionogi & Co., Ltd. Amine-derivatives having NPY Y5 receptor antagonistic activity and the uses thereof
SG194621A1 (en) 2011-04-27 2013-12-30 Shionogi & Co 5-membered ring aromatic heterocyclic derivative having npy y5 receptor antagonistic activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989379B1 (en) * 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists

Also Published As

Publication number Publication date
KR20080018206A (ko) 2008-02-27
NO20080411L (no) 2008-01-22
EA200800111A1 (ru) 2008-06-30
JP2008546787A (ja) 2008-12-25
AR054480A1 (es) 2007-06-27
AU2006262319A1 (en) 2007-01-04
CA2613377A1 (fr) 2007-01-04
CN101203499A (zh) 2008-06-18
IL187894A0 (en) 2008-03-20
BRPI0612270A2 (pt) 2016-09-06
WO2007002126A1 (fr) 2007-01-04
WO2007002126A8 (fr) 2007-03-01
MX2007015998A (es) 2008-03-07

Similar Documents

Publication Publication Date Title
TW200800979A (en) Halogenated sulfonamide derivatives
MY152949A (en) Novel phenylimidazole derivatives as pde10a enzyme inhibitors
UA102693C2 (ru) Производные фенилимидазола как ингибиторы фермента pde10a
TN2012000287A1 (en) 2-arylimidazole derivatives as pde10a enzyme inhibitors
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
IN2015DN02829A (fr)
WO2010053861A3 (fr) Amides biologiquement actifs
TN2012000278A1 (en) Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors
TN2012000271A1 (en) Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
EA200900048A1 (ru) Новые карбонилированные (аза)циклогексаны в качестве лигандов d3 рецептора дофамина
MX338831B (es) Moduladores selectivos de receptores de androgenos.
WO2009105214A3 (fr) Modulateurs sélectifs du récepteur de l'androgène
WO2010118287A8 (fr) Modulateurs sélectifs du récepteur aux androgènes
UA112065C2 (uk) Похідні імідазолу як інгібітори ферменту pde10a
MX2009003981A (es) Agentes moduladores del receptor de calcio.
NO20074047L (no) Ny fremgangsmate for fremstilling av substituerte indoler
WO2007114902A3 (fr) Composés d'alkylthiobenzylpipéridine
TW200736237A (en) Alkyl sulfonamide derivatives
MX2007003922A (es) Nuevas propenonas ciclicas y aciclicas para tratar trastornos del sistema nervioso central.
MX2012007005A (es) Tiazoles biciclicos como moduladores alostericos de recptores de glutamato metabotropico subtipo 5.
WO2007114916A3 (fr) Composés d'arylbenzylpipéridine
WO2006041636A3 (fr) Derives d'aryloxybenzylpiperidine amino-substitues
EA200601315A1 (ru) 4-арилпиперидины
WO2007092436A3 (fr) Composes pour le traitement de troubles inflammatoires, de troubles de demyelinisation et de cancers